1 |
Lee, T. J., Um, H. J., Min do, S., Park, J. W., Choi, K. S. and Kwon, T. K. 2009. Withaferin A sensitizes TRAIL-induced apoptosis through reactive oxygen species-mediated up-regulation of death receptor 5 and down-regulation of c-FLIP. Free Radic Biol Med 46, 1639-1649.
DOI
ScienceOn
|
2 |
Maitra, R., Porter, M. A., Huang, S. and Gilmour, B. P. 2009. Inhibition of NFkappaB by the natural product Withaferin A in cellular models of Cystic Fibrosis inflammation. J Inflamm (Lond) 6, 15-19.
DOI
ScienceOn
|
3 |
Malik, F., Kumar, A., Bhushan, S., Khan, S., Bhatia, A., Suri, K. A., Qazi, G. N. and Singh, J. 2007. Reactive oxygen species generation and mitochondrial dysfunction in the apoptotic cell death of human myeloid leukemia HL-60 cells by a dietary compound withaferin A with concomitant protection by N-acetyl cysteine. Apoptosis 12, 2115-2133.
DOI
|
4 |
Mandal, C., Dutta, A., Mallick, A., Chandra, S., Misra, L. and Sangwan, R. S. 2008. Withaferin A induces apoptosis by activating p38 mitogen-activated protein kinase signaling cascade in leukemic cells of lymphoid and myeloid origin through mitochondrial death cascade. Apoptosis 13, 1450-1464.
DOI
|
5 |
Manoharan, S., Panjamurthy, K., Balakrishnan, S., Vasudevan, K. and Vellaichamy, L. 2009. Circadian time-dependent chemopreventive potential of withaferin-A in 7,12-dimethylbenz[a]anthracene-induced oral carcinogenesis. Pharmacol Rep 61, 719-726.
DOI
|
6 |
Manoharan, S., Panjamurthy, K., Menon, V. P., Balakrishnan, S. and Alias, L. M. 2009. Protective effect of Withaferin-A on tumour formation in 7,12-dimethylbenz[a]anthracene induced oral carcinogenesis in hamsters. Indian J Exp Biol 47, 16-23.
|
7 |
Mayola, E., Gallerne, C., Esposti, D. D., Martel, C., Pervaiz, S., Larue, L., Debuire, B., Lemoine, A., Brenner, C. and Lemaire, C. 2011. Withaferin A induces apoptosis in human melanoma cells through generation of reactive oxygen species and down-regulation of Bcl-2. Apoptosis 16, 1014-1027.
DOI
ScienceOn
|
8 |
Miele, L. 2006. Notch signaling. Clin Cancer Res 12, 1074-1079.
DOI
ScienceOn
|
9 |
Bhattacharya, S. K., Satyan, K. S. and Ghosal, S. 1997. Antioxidant activity of glycowithanolides from Withania somnifera. Indian J Exp Biol 35, 236-239.
|
10 |
Boccaccio, C., Ando, M., Tamagnone, L., Bardelli, A., Michieli, P., Battistini, C. and Comoglio, P. M. 1998. Induction of epithelial tubules by growth factor HGF depends on the STAT pathway. Nature 391, 285-288.
DOI
ScienceOn
|
11 |
Choi, M. J., Park, E. J., Min, K. J., Park, J. W. and Kwon, T. K. 2011. Endoplasmic reticulum stress mediates withaferin A-induced apoptosis in human renal carcinoma cells. Toxicol In Vitro 25, 692-698.
DOI
ScienceOn
|
12 |
Choudhary, M. I., Hussain, S., Yousuf, S., Dar, A., Mudassar and Atta ur, R. 2010. Chlorinated and diepoxy withanolides from Withania somnifera and their cytotoxic effects against human lung cancer cell line. Phytochemistry 71, 2205-2209.
DOI
ScienceOn
|
13 |
Devi, P. U., Sharada, A. C. and Solomon, F. E. 1995. In vivo growth inhibitory and radiosensitizing effects of withaferin A on mouse Ehrlich ascites carcinoma. Cancer Lett 95, 189-193.
DOI
ScienceOn
|
14 |
Fuska, J., Fuskova, A., Rosazza, J. P. and Nicholas, A. W. 1984. Novel cytotoxic and antitumor agents. IV. Withaferin A: relation of its structure to the in vitro cytotoxic effects on P388 cells. Neoplasma 31, 31-36.
|
15 |
Misra, L., Lal, P., Chaurasia, N. D., Sangwan, R. S., Sinha, S. and Tuli, R. 2008. Selective reactivity of 2-mercaptoethanol with 5beta,6beta-epoxide in steroids from Withania somnifera. Steroids 73, 245-251.
DOI
ScienceOn
|
16 |
Mohan, R., Hammers, H. J., Bargagna-Mohan, P., Zhan, X. H., Herbstritt, C. J., Ruiz, A., Zhang, L., Hanson, A. D., Conner, B. P., Rougas, J. and Pribluda, V. S. 2004. Withaferin A is a potent inhibitor of angiogenesis. Angiogenesis 7, 115-122.
DOI
ScienceOn
|
17 |
Munagala, R., Kausar, H., Munjal, C. and Gupta, R. C. 2011. Withaferin A induces p53-dependent apoptosis by repression of HPV oncogenes and upregulation of tumor suppressor proteins in human cervical cancer cells. Carcinogenesis 32, 1697-1705.
DOI
ScienceOn
|
18 |
Goetsch, L., Caussanel, V. and Corvaia, N. 2013. Biological significance and targeting of c-Met tyrosine kinase receptor in cancer. Front Biosci 18, 454-473.
DOI
|
19 |
Grogan, P. T., Sleder, K. D., Samadi, A. K., Zhang, H., Timmermann, B. N. and Cohen, M. S. 2012. Cytotoxicity of withaferin A in glioblastomas involves induction of an oxidative stress-mediated heat shock response while altering Akt/mTOR and MAPK signaling pathways. Invest New Drugs. (In press)
|
20 |
Hahm, E. R. and Singh, S. V. 2012. Withaferin A-induced apoptosis in human breast cancer cells is associated with suppression of inhibitor of apoptosis family protein expression. Cancer Lett. (In press)
|
21 |
Ju, L. and Zhou, C. 2013. Association of integrin beta1 and c-MET in mediating EGFR TKI gefitinib resistance in non-small cell lung cancer. Cancer Cell Int 13, 15-22.
DOI
ScienceOn
|
22 |
Lee, J., Sehrawat, A. and Singh, S. V. 2012. Withaferin A causes activation of Notch2 and Notch4 in human breast cancer cells. Breast Cancer Res Treat 136, 45-56.
DOI
|
23 |
Sharada, A. C., Solomon, F. E., Devi, P. U., Udupa, N. and Srinivasan, K. K. 1996. Antitumor and radiosensitizing effects of withaferin A on mouse Ehrlich ascites carcinoma in vivo. Acta Oncol 35, 95-100.
DOI
|
24 |
Srinivasan, S., Ranga, R. S., Burikhanov, R., Han, S. S. and Chendil, D. 2007. Par-4-dependent apoptosis by the dietary compound withaferin A in prostate cancer cells. Cancer Res 67, 246-253.
DOI
ScienceOn
|
25 |
Lee, J., Hahm, E. R. and Singh, S. V. 2010. Withaferin A inhibits activation of signal transducer and activator of transcription 3 in human breast cancer cells. Carcinogenesis 31, 1991-1998.
DOI
ScienceOn
|
26 |
El-Guendy, N. and Rangnekar, V. M. 2003. Apoptosis by Par-4 in cancer and neurodegenerative diseases. Exp Cell Res 283, 51-66.
DOI
ScienceOn
|
27 |
Kaileh, M., Vanden Berghe, W., Heyerick, A., Horion, J., Piette, J., Libert, C., De Keukeleire, D., Essawi, T. and Haegeman, G. 2007. Withaferin a strongly elicits IkappaB kinase beta hyperphosphorylation concomitant with potent inhibition of its kinase activity. J Biol Chem 282, 4253-4264.
DOI
ScienceOn
|
28 |
Kalthur, G. and Pathirissery, U. D. 2010. Enhancement of the response of B16F1 melanoma to fractionated radiotherapy and prolongation of survival by withaferin A and/or hyperthermia. Integr Cancer Ther 9, 370-377.
DOI
ScienceOn
|
29 |
Koduru, S., Kumar, R., Srinivasan, S., Evers, M. B. and Damodaran, C. 2010. Notch-1 inhibition by Withaferin-A: a therapeutic target against colon carcinogenesis. Mol Cancer Ther 9, 202-210.
|
30 |
Fong, M. Y., Jin, S., Rane, M., Singh, R. K., Gupta, R. and Kakar, S. S. 2012. Withaferin A synergizes the therapeutic effect of doxorubicin through ROS-mediated autophagy in ovarian cancer. PLoS One 7, e42265-e42280.
DOI
|
31 |
Affar el, B., Luke, M. P., Gay, F., Calvo, D., Sui, G., Weiss, R. S., Li, E. and Shi, Y. 2006. Targeted ablation of Par-4 reveals a cell type-specific susceptibility to apoptosis-inducing agents. Cancer Res 66, 3456-3462.
DOI
ScienceOn
|
32 |
Archana, R. and Namasivayam, A. 1999. Antistressor effect of Withania somnifera. J Ethnopharmacol 64, 91-93.
|
33 |
Bargagna-Mohan, P., Hamza, A., Kim, Y. E., Khuan Abby Ho, Y., Mor-Vaknin, N., Wendschlag, N., Liu, J., Evans, R. M., Markovitz, D. M., Zhan, C. G., Kim, K. B. and Mohan, R. 2007. The tumor inhibitor and antiangiogenic agent with-aferin A targets the intermediate filament protein vimentin. Chem Biol 14, 623-634.
DOI
ScienceOn
|
34 |
Bhatnagar, M., Sisodia, S. S. and Bhatnagar, R. 2005. Antiulcer and antioxidant activity of Asparagus racemosus Willd and Withania somnifera Dunal in rats. Ann N Y Acad Sci 1056, 261-278.
DOI
ScienceOn
|
35 |
Rah, B., Amin, H., Yousuf, K., Khan, S., Jamwal, G., Mukherjee, D. and Goswami, A. 2012. A novel MMP-2 inhibitor 3-azidowithaferin A (3-azidoWA) abrogates cancer cell invasion and angiogenesis by modulating extracellular Par-4. PLoS One 7, e44039-e44052.
DOI
|
36 |
Oh, J. H., Lee, T. J., Kim, S. H., Choi, Y. H., Lee, S. H., Lee, J. M., Kim, Y. H., Park, J. W. and Kwon, T. K. 2008. Induction of apoptosis by withaferin A in human leukemia U937 cells through down-regulation of Akt phosphorylation. Apoptosis 13, 1494-1504.
DOI
|
37 |
Pan, G., Ni, J., Wei, Y. F., Yu, G., Gentz, R. and Dixit, V. M. 1997. An antagonist decoy receptor and a death domain- containing receptor for TRAIL. Science 277, 815-818.
DOI
ScienceOn
|
38 |
Peters, S. and Adjei, A. A. 2012. MET: a promising anticancer therapeutic target. Nat Rev Clin Oncol 9, 314-326.
DOI
ScienceOn
|
39 |
Samadi, A. K., Cohen, S. M., Mukerji, R., Chaguturu, V., Zhang, X., Timmermann, B. N., Cohen, M. S. and Person, E. A. 2012. Natural withanolide withaferin A induces apoptosis in uveal melanoma cells by suppression of Akt and c-MET activation. Tumour Biol 33, 1179-1189.
DOI
ScienceOn
|
40 |
Rasool, M. and Varalakshmi, P. 2006. Immunomodulatory role of Withania somnifera root powder on experimental induced inflammation: An in vivo and in vitro study. Vascul Pharmacol 44, 406-410.
DOI
ScienceOn
|
41 |
Santagata, S., Xu, Y. M., Wijeratne, E. M., Kontnik, R., Rooney, C., Perley, C. C., Kwon, H., Clardy, J., Kesari, S., Whitesell, L., Lindquist, S. and Gunatilaka, A. A. 2012. Using the heat-shock response to discover anticancer compounds that target protein homeostasis. ACS Chem Biol 7, 340-349.
DOI
ScienceOn
|
42 |
Schroder, M. and Kaufman, R. J. 2005. The mammalian unfolded protein response. Annu Rev Biochem 74, 739-789.
DOI
ScienceOn
|
43 |
Sells, S. F., Wood, D. P., Jr., Joshi-Barve, S. S., Muthukumar, S., Jacob, R. J., Crist, S. A., Humphreys, S. and Rangnekar, V. M. 1994. Commonality of the gene programs induced by effectors of apoptosis in androgen-dependent and -independent prostate cells. Cell Growth Differ 5, 457-466.
|
44 |
Yang, H., Shi, G. and Dou, Q. P. 2007. The tumor proteasome is a primary target for the natural anticancer compound Withaferin A isolated from "Indian winter cherry". Mol Pharmacol 71, 426-437.
|
45 |
Yang, H., Wang, Y., Cheryan, V. T., Wu, W., Cui, C. Q., Polin, L. A., Pass, H. I., Dou, Q. P., Rishi, A. K. and Wali, A. 2012. Withaferin a inhibits the proteasome activity in mesothelioma in vitro and in vivo. PLoS One 7, e41214-e41213.
DOI
|
46 |
Yoshida, H., Matsui, T., Yamamoto, A., Okada, T. and Mori, K. 2001. XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor. Cell 107, 881-891.
DOI
ScienceOn
|
47 |
Stan, S. D., Zeng, Y. and Singh, S. V. 2008. Ayurvedic medicine constituent withaferin a causes G2 and M phase cell cycle arrest in human breast cancer cells. Nutr Cancer 60 Suppl 1, 51-60.
DOI
ScienceOn
|
48 |
Yousuf, S. K., Majeed, R., Ahmad, M., Sangwan, P., Purnima, B., Saxsena, A. K., Suri, K. A., Mukherjee, D. and Taneja, S. C. 2011. Ring A structural modified derivatives of withaferin A and the evaluation of their cytotoxic potential. Steroids 76, 1213-1222.
DOI
ScienceOn
|
49 |
Yu, Y., Hamza, A., Zhang, T., Gu, M., Zou, P., Newman, B., Li, Y., Gunatilaka, A. A., Zhan, C. G. and Sun, D. 2010. Withaferin A targets heat shock protein 90 in pancreatic cancer cells. Biochem Pharmacol 79, 542-551.
DOI
ScienceOn
|
50 |
Stan, S. D., Hahm, E. R., Warin, R. and Singh, S. V. 2008. Withaferin A causes FOXO3a- and Bim-dependent apoptosis and inhibits growth of human breast cancer cells in vivo. Cancer Res 68, 7661-7669.
DOI
ScienceOn
|
51 |
Nicolas, M., Wolfer, A., Raj, K., Kummer, J. A., Mill, P., van Noort, M., Hui, C. C., Clevers, H., Dotto, G. P. and Radtke, F. 2003. Notch1 functions as a tumor suppressor in mouse skin. Nat Genet 33, 416-421.
DOI
ScienceOn
|
52 |
Noh, H. J., Lee, S. J., Sung, E. G., Song, I. H., Kim, J. Y., Woo, C. H., Kwon, T. K. and Lee, T. J. 2012. CHOP down-regulates cFLIP(L) expression by promoting ubiquitin/ proteasome-mediated cFLIP(L) degradation. J Cell Biochem 113, 3692-3700.
DOI
ScienceOn
|
53 |
Zhang, X., Mukerji, R., Samadi, A. K. and Cohen, M. S. 2011. Down-regulation of estrogen receptor-alpha and rearranged during transfection tyrosine kinase is associated with withaferin a-induced apoptosis in MCF-7 breast cancer cells. BMC Complement Altern Med 11, 84-93.
DOI
|
54 |
Zhang, X., Samadi, A. K., Roby, K. F., Timmermann, B. and Cohen, M. S. 2012. Inhibition of cell growth and induction of apoptosis in ovarian carcinoma cell lines CaOV3 and SKOV3 by natural withanolide Withaferin A. Gynecol Oncol 124, 606-612.
DOI
ScienceOn
|
55 |
Thaiparambil, J. T., Bender, L., Ganesh, T., Kline, E., Patel, P., Liu, Y., Tighiouart, M., Vertino, P. M., Harvey, R. D., Garcia, A. and Marcus, A. I. 2011. Withaferin A inhibits breast cancer invasion and metastasis at sub-cytotoxic doses by inducing vimentin disassembly and serine 56 phosphorylation. Int J Cancer 129, 2744-2755.
DOI
ScienceOn
|
56 |
Stephanou, A. 2004. Role of STAT-1 and STAT-3 in ischaemia/ reperfusion injury. J Cell Mol Med 8, 519-525.
DOI
ScienceOn
|
57 |
Suttana, W., Mankhetkorn, S., Poompimon, W., Palagani, A., Zhokhov, S., Gerlo, S., Haegeman, G. and Berghe, W. V. 2010. Differential chemosensitization of P-glycoprotein overexpressing K562/Adr cells by withaferin A and Siamois polyphenols. Mol Cancer 9, 99-120.
DOI
ScienceOn
|
58 |
Szegezdi, E., Logue, S. E., Gorman, A. M. and Samali, A. 2006. Mediators of endoplasmic reticulum stress-induced apoptosis. EMBO Rep 7, 880-885.
DOI
ScienceOn
|
59 |
Um, H. J., Min, K. J., Kim, D. E. and Kwon, T. K. 2012. Withaferin A inhibits JAK/STAT3 signaling and induces apoptosis of human renal carcinoma Caki cells. Biochem Biophys Res Commun 427, 24-29.
DOI
ScienceOn
|
60 |
Yang, E. S., Choi, M. J., Kim, J. H., Choi, K. S. and Kwon, T. K. 2011. Combination of withaferin A and X-ray irradiation enhances apoptosis in U937 cells. Toxicol In Vitro 25, 1803-1810.
DOI
ScienceOn
|
61 |
Yang, E. S., Choi, M. J., Kim, J. H., Choi, K. S. and Kwon, T. K. 2011. Withaferin A enhances radiation-induced apoptosis in Caki cells through induction of reactive oxygen species, Bcl-2 downregulation and Akt inhibition. Chem Biol Interact 190, 9-15.
DOI
ScienceOn
|